about
Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000).Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database.Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data.Non-medical exposure to radioiodines and thyroid cancer.Childhood adversity as a risk for cancer: findings from the 1958 British birth cohort study.Total and partial cancer prevalence in the adult French population in 2008Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.Evaluation of the management of rectal cancers before and after the consensus conference in France.Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.The care center influences the management of lymphoma patients in a universal health care system: an observational cohort studyPrevalence of cancer in the elderly: discrepancies between self-reported and registry dataAssessment of the ecological bias of seven aggregate social deprivation indicesConstruction of an adaptable European transnational ecological deprivation index: the French version.Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry.Breast cancer survival in the US and Europe: a CONCORD high-resolution study.Methodological considerations in cost of prostate cancer studies: a systematic review.Adverse childhood experiences and premature all-cause mortality.Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis.A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.The embodiment of adverse childhood experiences and cancer development: potential biological mechanisms and pathways across the life course.Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study.Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.Survival of solid cancer patients in France, 1989-2013: a population-based study.Are disparities of waiting times for breast cancer care related to socio-economic factors? A regional population-based study (France).Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.Cancer incidence among adolescents in France.Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France.Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.A population-based study on management of prostate cancer in four regions of France.Enabling the transferability of complex interventions: exploring the combination of an intervention's key functions and implementation.Guideline sheets on the side effects of anticancer drugs are useful for general practitioners.[Prostate cancer incidence and mortality trends in France from 1980 to 2011].[Epidemiology of thyroid carcinoma over the world].Unbiased estimates of long-term net survival of solid cancers in France.Cancer incidence and mortality in France in 1975-95.Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005.[Female genital and breast cancers in France: geographic distribution and estimation of incidence][Alcohol consumption by young adults from three cities in Southern France]
P50
Q30563963-D754F056-9B09-435E-85A8-FC04475923C2Q31099314-FFFB8754-DA15-43AD-A5F1-EDE93FD25D78Q31119095-AF9B5EFE-C3A6-4E28-BF85-90FD3144168CQ33605064-BD9E418B-C2BE-4881-81C5-9859DE59502DQ34794159-BA386DD0-A7E8-4095-9FDD-2EEE4F57C3D9Q34955861-DE94E326-2814-4ED6-8BCD-39E175FA80A4Q35204233-273FEF9C-C914-4CE9-8F6E-9C0044676671Q35214578-311D03AC-C58A-4BFE-B926-D6C722A4D3E2Q35889479-90901E61-D761-4231-A324-D82B9FA6AE23Q36009325-3CB4B226-CE40-4429-BC19-718A57F7337AQ36093253-23B2B059-0271-4D84-BD4F-33EF3A24DA5FQ36116346-EEFAED3B-1F70-4569-9F8A-7F1B9604E265Q36251792-99E43CBD-D7A6-4EE8-AEDB-F7423BEFFEA3Q36302174-437F95D2-960A-4E91-924D-ABA22CF7C676Q36318112-89E91058-5BA8-4908-AEFB-4A5BBCF6B66DQ36446450-DC5103B7-5B2D-4850-8890-509BFC07CFBFQ37169697-C44D25DA-CCF2-4A90-8240-16750FE19203Q37209253-07A3FE88-E294-4949-B488-CA427A24CCC6Q37634406-675EDA87-32E4-4C9D-BA5B-3B6A99D0EB2FQ37676436-632ED7A1-BF56-4564-B5E1-17A8B3E8DFC2Q38010316-CA5C78A2-A377-4832-81EA-E755DC406442Q38411883-84437861-5B7F-4EBD-BB04-A946C746B6E0Q38417399-30476F31-6753-40C8-A69C-75240B8E2F4DQ38426380-DB86C8DA-716F-45AB-A032-1EF76ED9915AQ38734102-1BB9493B-6E31-43CD-B4F1-B85BB6E5F727Q39609328-5DECF8B5-B090-4052-801C-DD5FEAE800ABQ40151527-3715EEEB-306B-4593-963D-99D0772C0A75Q40480171-BE85A60E-1389-478E-BF7B-0C0C61AAC3A7Q40505896-CEA01A92-AFCE-4CAC-A51D-57D6FE8D4A8EQ40525841-BA1162E3-8273-499C-BF4F-B28464A278E5Q40614060-E3D1BFCC-F44B-4DEA-95F0-15668EA6BDC9Q40807912-05CB0C99-CBED-4131-9252-9BD7EA45A5B6Q41151846-AC3D21BF-5733-4E78-809F-70D56D23F168Q41693584-279A97C6-F508-4705-BC1C-B409AFF91AA3Q43652981-8ECCA83C-BFEC-4C2B-8D50-F847B9B1631CQ43692577-6D36296B-F9AB-4758-8E7A-FF0EE83919C2Q43991509-CA4A5E34-395B-4C69-9C1F-4B768B03E6A3Q44017277-7CF655D5-500D-41FF-9CB0-09657EB2FC8AQ44173257-0DADF54A-3735-448B-9EE9-91D5A6583754Q44222855-39350D67-163D-4F9B-AAE9-081BD4569925
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pascale Grosclaude
@ast
Pascale Grosclaude
@en
Pascale Grosclaude
@es
Pascale Grosclaude
@nl
type
label
Pascale Grosclaude
@ast
Pascale Grosclaude
@en
Pascale Grosclaude
@es
Pascale Grosclaude
@nl
prefLabel
Pascale Grosclaude
@ast
Pascale Grosclaude
@en
Pascale Grosclaude
@es
Pascale Grosclaude
@nl
P106
P21
P31
P496
0000-0002-6755-5970